http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4942036-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad48c6b5a0867d72e4926d8961d9a685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0571016e64a7dcdc7288567a97561632
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2984
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
filingDate 1988-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1990-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee519681e1c3fa0c7a557c2b53d95407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bc32460f4af1b38c586e4913d674c6d
publicationDate 1990-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4942036-A
titleOfInvention Therapy by vesicle delivery to the hydroxyapatite of bone
abstract A known procedure is used to prepare vesicles consisting of bipolar lipid membranes which are permeable and hence "leak" their contents at a rate which is variable by choice. The vesicle is supplied with medication or diagnostic material and then attached to a target molecule conjugate that has affinity for the hydroxyapatite of bone. Thus, the vesicle clings to the skeleton structure and bathes the surrounding support surface with its contents for extended hours.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8303983-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005070952-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6589555-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005020965-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5139786-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7381426-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010209492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7169410-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010015068-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5173303-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005053668-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003203038-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5300281-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009311327-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007154537-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005020965-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007104777-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7455856-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9800112-A1
priorityDate 1988-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4698328-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4603044-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4193983-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4767615-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4501728-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4544545-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4692433-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426222304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16081932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128417629

Total number of triples: 47.